Cargando…
Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma
BACKGROUND: This study sought to predict the early responses to neoadjuvant chemotherapy (NACT) of patients with primary conventional osteosarcoma (COS) using the apparent diffusion coefficient (ADC) and to evaluate the factors affecting the tumor necrosis rate (TNR). METHODS: The data of 41 patient...
Autores principales: | Yu, Hong, Gao, Lei, Shi, Ruiqing, Kong, Mengjuan, Duan, Lisha, Cui, Jianling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240025/ https://www.ncbi.nlm.nih.gov/pubmed/37284107 http://dx.doi.org/10.21037/qims-22-1095 |
Ejemplares similares
-
Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma
por: Erdoğan, Furkan, et al.
Publicado: (2023) -
Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings
por: Liu, Chenglei, et al.
Publicado: (2019) -
Early response monitoring of neoadjuvant chemotherapy using [(18)F]FDG PET can predict the clinical outcome of extremity osteosarcoma
por: Lee, Inki, et al.
Publicado: (2020) -
A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma
por: Lin, Peng, et al.
Publicado: (2020) -
Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy
por: Trieb, K, et al.
Publicado: (2000)